Skip to search form
Skip to main content
Create Free Account
You are currently offline. Some features of the site may not work correctly.
National Institutes of Health
Semantic Scholar uses AI to extract papers important to this topic.
First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer…
Annals of the rheumatic diseases
Corpus ID: 19830883
Background: The heteropolymer technology was developed to remove pathogens from the circulation. Objectives: To evaluate the…
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Terms of Service
ACCEPT & CONTINUE